Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients
Clinical trial NCT00706992 · TERMINATED
Trial details
- NCT number
- NCT00706992
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2012-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.